STOCK TITAN
  1. Home
  2. News
  3. OFIX

Orthofix Medical Inc - OFIX STOCK NEWS

Welcome to our dedicated news page for Orthofix Medical (Ticker: OFIX), a resource for investors and traders seeking the latest updates and insights on Orthofix Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Orthofix Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Orthofix Medical's position in the market.

News
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ:OFIX) announced new data from a study on Pulsed Electromagnetic Field (PEMF) stimulation as a therapy for spinal fusion procedures. The study showed a high rate of successful fusion and significant improvements in pain, function, and quality of life for patients at risk for pseudarthrosis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.66%
Tags
none
-
News
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ: OFIX) announced the appointment of three new independent directors to the Company’s Board. The new directors bring substantial finance, strategic development, healthcare and medical technology experience to further advance Orthofix’s position as a leading global spine and orthopedics company. The appointments follow constructive engagement and entry into a cooperation agreement with Engine Capital Management, LP, one of the Company’s largest shareholders. The three new independent directors joining the Orthofix Board are: Alan Bazaar, Chief Executive Officer of wealth management firm Hollow Brook Wealth Management LLC; Michael Finegan, Chief Executive Officer of Acera Surgical and former Chief Strategy Officer of Orthofix; and Charles Kummeth, President and Chief Executive Officer of Bio-Techne Corporation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News
Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc
Rhea-AI Summary
Orthofix Medical Inc. (OFIX) announces the publication of the five-year results from the U.S. clinical study comparing the M6-C artificial cervical disc with anterior cervical discectomy and fusion (ACDF). The study demonstrates superior clinical success of the M6-C disc at 60 months compared to ACDF patients, with significant improvements in neck and arm pain, function, and quality of life scores. The M6-C artificial disc has received U.S. FDA approval and has had over 100,000 implantations worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
News
Orthofix Names Massimo Calafiore as President and Chief Executive Officer
Rhea-AI Summary
Orthofix Medical Inc. (OFIX) has announced the appointment of Massimo Calafiore as the incoming President and CEO. Mr. Calafiore, currently the CEO of LimaCorporate S.p.A., will take over in early 2024, following LimaCorporate's acquisition by Enovis Corporation. The board unanimously chose Mr. Calafiore for his proven track record in delivering value creation and extensive knowledge of the orthopedics and spine industry. His appointment is expected to drive significant profitable growth and enhance shareholder value for Orthofix.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
none
-
News
Orthofix Reports Third Quarter 2023 Results
Rhea-AI Summary
Orthofix Medical Inc. (NASDAQ:OFIX) entered into a new four-year financing agreement with a borrowing capacity of up to $150 million. The company reported net sales of $184.0 million, a 61% increase on a reported basis and an 8% increase on a pro forma basis. Adjusted EBITDA was $13.5 million, representing 36% sequential growth over the second quarter of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.37%
Tags
earnings
-
News
Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures
Rhea-AI Summary
Orthofix Medical Inc. has announced the full U.S. commercial launch of the WaveForm® L Lateral Lumbar Interbody System. The 3D-printed system is designed for lateral lumbar interbody fusion (LLIF) procedures and features a porous structure for strength and stability. The system has improved imaging characteristics and is expected to contribute to the growing LLIF market, which is estimated to be over $350 million in the U.S.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
none
News
Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023
Rhea-AI Summary
Orthofix Medical Inc. to release Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.66%
Tags
earnings
-
News
Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures
Rhea-AI Summary
Orthofix Medical Inc. announces the clearance and launch of OsteoCove, an advanced bioactive synthetic graft.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.41%
Tags
none
-
News
Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures
Rhea-AI Summary
Orthofix Medical Inc. announces full U.S. commercial launch of Galaxy Fixation Gemini system for treating fractures resulting from trauma in limbs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
News
Orthofix Announces Leadership Changes
Rhea-AI Summary
Orthofix Medical Inc. announces leadership changes and postpones investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.17%
Tags
management
Stock OFIX logo
Orthofix Medical Inc

Nasdaq:OFIX

OFIX Rankings

#2998 Ranked by Market Cap
#4011 Ranked by Stock Gains
N/A Ranked by Dividends

OFIX Stock Data

498.26M
26.16M
3.45%
97.5%
10.25%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Lewisville

About OFIX

orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing